10.1152/physrev.00034.2006 [DOI] [PubMed] [Google Scholar] Holst, J
"For someone with type 2 diabetes or significant obesity, the cardiovascular, kidney and metabolic benefits [of these medications] are large and well-established, and stopping abruptly carries its own risks, so any change should be a conversation with your prescriber," he said
Legal status varies by jurisdiction, and researchers should understand the regulatory framework in their location before acquiring either compound
Tirzepatide lowers your metabolic rate as you lose weight and activates appetite-suppressing pathways in your brain's temperature-control center (hypothalamus)
In this context, disruption of temporal coordination, rather than hormone abundance alone, may limit effective engagement of melatonin-dependent immunoregulatory pathways
One such study showed that chronic daily administration of GIP analogues decreased food intake and resulted in body weight reduction in diet-induced obese mice without alterations in energy expenditure [73]